Sebastien Serres1, Silvy Mardiguian2,
Martina A. McAteer3, Robin P. Choudhury4, Sandra J.
Campbell5, Paul Smith6, Fay Saunders7,
Nicola R. Sibson8, Daniel C. Anthony2
1Gray Institute for Radiation Oncology
and Biology, Oxford, Oxon, United Kingdom; 2Department of
Pharmacology, University of Oxford; 3Department of Cardiovascular
Medicine; 4Department of Cardiovascular Medicine, University of
Oxford; 5Department of Pharmacology, university of Oxford; 6Department
of Pharmacology, UCB, Slough; 7Department of Antibody Biology,
UCB, Slough,; 8Gray Institute for Radiation Oncology and Biology,
University of Oxford
Anti-IL17
treatment reduces clinical score and VCAM-1 expression in EAE-ABH mice
detected by in vivo magnetic resonance imaging